Superior bioavailability of the calcium salt form of ß-hydroxy-ß-methylbutyrate compared with the free acid form.

We investigated the bioavailability of the calcium salt (HMB-Ca) and the free acid (HMB-FA) forms of ß-hydroxy-ß-methylbutyrate (HMB). Sixteen young individuals received the following treatments on three different occasions in a counterbalanced crossover fashion: (1) HMB-FA in clear capsules; (2) HMB-Ca in gelatine capsules; (3) HMB-Ca dissolved in water. All treatments provided 1 g of HMB. Blood samples were taken before and on multiple time points following ingestion. The following parameters were calculated: peak plasma (Cmax), time to peak (Tmax), slope of HMB appearance in blood, area under the curve (AUC), half-life time (t1/2) and relative bioavailability (HMB-Ca in water set as reference). All treatments led to rapid and large increases in plasma HMB. HMB-Ca in capsules and in water showed similar plasma HMB values across time (p = 0.438). HMB-FA resulted in lower concentrations vs. the other treatments (both p < 0.001). AUC (HMB-Ca in capsules: 50,078 ± 10,507; HMB-Ca in water: 47,871 ± 10,783; HMB-FA: 29,130 ± 12,946 µmol L-1 × 720 min), Cmax (HMB-Ca in capsules: 229.2 ± 65.9; HMB-Ca in water: 249.7 ± 49.7; HMB-FA: 139.1 ± 67.2 µmol L-1) and relative bioavailability (HMB-Ca in capsules: 104.8 ± 14.9%; HMB-FA: 61.5 ± 17.0%) were lower in HMB-FA vs. HMB-Ca (all p < 0.001). HMB-Ca in water resulted in the fastest Tmax (43 ± 22 min) compared to HMB-Ca in capsules (79 ± 40 min) and HMB-FA (78 ± 21 min) (all p < 0.05), while t1/2 was similar between treatments. To conclude, HMB-Ca exhibited superior bioavailability compared to HMB-FA, with HMB-Ca in water showing faster absorption. Elimination kinetics were similar across all forms, suggesting that the pharmaceutical form of HMB affects the absorption rates, but not its distribution or elimination.

Potential of Creatine in Glucose Management and Diabetes.

Creatine is one of the most popular supplements worldwide, and it is frequently used by both athletic and non-athletic populations to improve power, strength, muscle mass and performance. A growing body of evidence has been identified potential therapeutic effects of creatine in a wide variety of clinical conditions, such as cancer, muscle dystrophy and neurodegenerative disorders. Evidence has suggested that creatine supplementation alone, and mainly in combination with exercise training, may improve glucose metabolism in health individuals and insulin-resistant individuals, such as in those with type 2 diabetes mellitus. Creatine itself may stimulate insulin secretion in vitro, improve muscle glycogen stores and ameliorate hyperglycemia in animals. In addition, exercise induces numerous metabolic benefits, including increases in insulin-independent muscle glucose uptake and insulin sensitivity. It has been speculated that creatine supplementation combined with exercise training could result in additional improvements in glucose metabolism when compared with each intervention separately. The possible mechanism underlying the effects of combined exercise and creatine supplementation is an enhanced glucose transport into muscle cell by type 4 glucose transporter (GLUT-4) translocation to sarcolemma. Although preliminary findings from small-scale trials involving patients with type 2 diabetes mellitus are promising, the efficacy of creatine for improving glycemic control is yet to be confirmed. In this review, we aim to explore the possible therapeutic role of creatine supplementation on glucose management and as a potential anti-diabetic intervention, summarizing the current knowledge and highlighting the research gaps.

Effect of age, diet, and tissue type on PCr response to creatine supplementation.

Creatine/phosphorylcreatine (PCr) responses to creatine supplementation may be modulated by age, diet, and tissue, but studies assessing this possibility are lacking. Therefore we aimed to determine whether PCr responses vary as a function of age, diet, and tissue. Fifteen children, 17 omnivorous and 14 vegetarian adults, and 18 elderly individuals ("elderly") participated in this study. Participants were given placebo and subsequently creatine (0.3 g·kg-1·day-1) for 7 days in a single-blind fashion. PCr was measured through phosphorus magnetic resonance spectroscopy (31P-MRS) in muscle and brain. Creatine supplementation increased muscle PCr in children (P < 0.0003) and elderly (P < 0.001), whereas the increase in omnivores did not reach statistically significant difference (P = 0.3348). Elderly had greater PCr increases than children and omnivores (P < 0.0001 for both), whereas children experienced greater PCr increases than omnivores (P = 0.0022). In relation to diet, vegetarians (P < 0.0001), but not omnivores, had significant increases in muscle PCr content. Brain PCr content was not affected by creatine supplementation in any group, and delta changes in brain PCr (-0.7 to +3.9%) were inferior to those in muscle PCr content (+10.3 to +27.6%; P < 0.0001 for all comparisons). PCr responses to a standardized creatine protocol (0.3 g·kg-1·day-1 for 7 days) may be affected by age, diet, and tissue. Whereas creatine supplementation was able to increase muscle PCr in all groups, although to different extents, brain PCr was shown to be unresponsive overall. These findings demonstrate the need to tailor creatine protocols to optimize creatine/PCr accumulation both in muscle and in brain, enabling a better appreciation of the pleiotropic properties of creatine.NEW & NOTEWORTHY A standardized creatine supplementation protocol (0.3 g·kg-1·day-1 for 7 days) effectively increased muscle, but not brain, phosphorylcreatine. Older participants responded better than younger participants whereas vegetarians responded better than omnivores. Responses to supplementation are thus dependent on age, tissue, and diet. This suggests that a single "universal" protocol, originally designed for increasing muscle creatine in young individuals, may lead to heterogeneous muscle responses in different populations or even no responses in tissues other than skeletal muscle.

Efficacy and safety of creatine supplementation in juvenile dermatomyositis: A randomized, double-blind, placebo-controlled crossover trial.

INTRODUCTION: It has been suggested that creatine supplementation is safe and effective for treating idiopathic inflammatory myopathies, but no pediatric study has been conducted to date. The objective of this study was to examine the efficacy and safety of creatine supplementation in juvenile dermatomyositis (JDM) patients. METHODS: In this study, JDM patients received placebo or creatine supplementation (0.1 g/kg/day) in a randomized, crossover, double-blind design. Subjects were assessed at baseline and after 12 weeks. The primary outcome was muscle function. Secondary outcomes included body composition, aerobic conditioning, health-related quality of life, and muscle phosphocreatine (PCr) content. Safety was assessed by laboratory parameters and kidney function measurements. RESULTS: Creatine supplementation did not affect muscle function, intramuscular PCr content, or any other secondary outcome. Kidney function was not affected, and no side effects were reported. CONCLUSIONS: Twelve weeks of creatine supplementation in JDM patients were well-tolerated and free of adverse effects, but treatment did not affect muscle function, intramuscular PCr, or any other parameter.

Can creatine supplementation form carcinogenic heterocyclic amines in humans?

There is a long-standing concern that creatine supplementation could be associated with cancer, possibly by facilitating the formation of carcinogenic heterocyclic amines (HCAs). This study provides compelling evidence that both low and high doses of creatine supplementation, given either acutely or chronically, does not cause a significant increase in HCA formation. HCAs detection was unrelated to creatine supplementation. Diet was likely to be the main factor responsible for HCAs formation after either placebo (n = 6) or creatine supplementation (n = 3). These results directly challenge the recently suggested biological plausibility for the association between creatine use and risk of testicular germ cell cancer. Creatine supplementation has been associated with increased cancer risk. In fact, there is evidence indicating that creatine and/or creatinine are important precursors of carcinogenic heterocyclic amines (HCAs). The present study aimed to investigate the acute and chronic effects of low- and high-dose creatine supplementation on the production of HCAs in healthy humans (i.e. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (8-MeIQx), 2-amino-(1,6-dimethylfuro[3,2-e]imidazo[4,5-b])pyridine (IFP) and 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline (4,8-DiMeIQx)). This was a non-counterbalanced single-blind crossover study divided into two phases, in which low- and high-dose creatine protocols were tested. After acute (1 day) and chronic supplementation (30 days), the HCAs PhIP, 8-MeIQx, IFP and 4,8-DiMeIQx were assessed through a newly developed HPLC-MS/MS method. Dietary HCA intake and blood and urinary creatinine were also evaluated. Out of 576 assessments performed (from 149 urine samples), only nine (3 from creatine and 6 from placebo) showed quantifiable levels of HCAs (8-MeIQx: n = 3; 4,8-DiMeIQx: n = 2; PhIP: n = 4). Individual analyses revealed that diet rather than creatine supplementation was the main responsible factor for HCA formation in these cases. This study provides compelling evidence that both low and high doses of creatine supplementation, given either acutely or chronically, did not cause increases in the carcinogenic HCAs PhIP, 8-MeIQx, IFP and 4,8-DiMeIQx in healthy subjects. These findings challenge the long-existing notion that creatine supplementation could potentially increase the risk of cancer by stimulating the formation of these mutagens.

Effects of beta-alanine supplementation on brain homocarnosine/carnosine signal and cognitive function: an exploratory study.

OBJECTIVES: Two independent studies were conducted to examine the effects of 28 d of beta-alanine supplementation at 6.4 g d(-1) on brain homocarnosine/carnosine signal in omnivores and vegetarians (Study 1) and on cognitive function before and after exercise in trained cyclists (Study 2). METHODS: In Study 1, seven healthy vegetarians (3 women and 4 men) and seven age- and sex-matched omnivores undertook a brain 1H-MRS exam at baseline and after beta-alanine supplementation. In study 2, nineteen trained male cyclists completed four 20-Km cycling time trials (two pre supplementation and two post supplementation), with a battery of cognitive function tests (Stroop test, Sternberg paradigm, Rapid Visual Information Processing task) being performed before and after exercise on each occasion. RESULTS: In Study 1, there were no within-group effects of beta-alanine supplementation on brain homocarnosine/carnosine signal in either vegetarians (p = 0.99) or omnivores (p = 0.27); nor was there any effect when data from both groups were pooled (p = 0.19). Similarly, there was no group by time interaction for brain homocarnosine/carnosine signal (p = 0.27). In study 2, exercise improved cognitive function across all tests (P < 0.05), although there was no effect (P>0.05) of beta-alanine supplementation on response times or accuracy for the Stroop test, Sternberg paradigm or RVIP task at rest or after exercise. CONCLUSION: 28 d of beta-alanine supplementation at 6.4 g d(-1) appeared not to influence brain homocarnosine/carnosine signal in either omnivores or vegetarians; nor did it influence cognitive function before or after exercise in trained cyclists.

Influence of training status on high-intensity intermittent performance in response to ß-alanine supplementation.

Recent investigations have suggested that highly trained athletes may be less responsive to the ergogenic effects of ß-alanine (BA) supplementation than recreationally active individuals due to their elevated muscle buffering capacity. We investigated whether training status influences the effect of BA on repeated Wingate performance. Forty young males were divided into two groups according to their training status (trained: T, and non-trained: NT cyclists) and were randomly allocated to BA and a dextrose-based placebo (PL) groups, providing four experimental conditions: NTPL, NTBA, TPL, TBA. BA (6.4 g day(-1)) or PL was ingested for 4 weeks, with participants completing four 30-s lower-body Wingate bouts, separated by 3 min, before and after supplementation. Total work done was significantly increased following supplementation in both NTBA (p = 0.03) and TBA (p = 0.002), and it was significantly reduced in NTPL (p = 0.03) with no difference for TPL (p = 0.73). BA supplementation increased mean power output (MPO) in bout 4 for the NTBA group (p = 0.0004) and in bouts 1, 2 and 4 for the TBA group (p ≤ 0.05). No differences were observed in MPO for NTPL and TPL. BA supplementation was effective at improving repeated high-intensity cycling performance in both trained and non-trained individuals, highlighting the efficacy of BA as an ergogenic aid for high-intensity exercise regardless of the training status of the individual.

Eficácia e segurança da suplementação de creatina em pacientes com dermatomiosite de início juvenil / Safety and efficacy of creatine supplementation in juvenile dermatomyositis

Introdução: A dermatomiosite juvenil (DMJ) é uma doença autoimune idiopática caracterizada pela presença de lesão cutânea, perda de massa muscular, fraqueza muscular proximal, fadiga e redução da aptidão física. Nesse contexto, a suplementação de creatina emerge como estratégia terapêutica não farmacológica para atenuar os sintomas ocasionados pela disfunção muscular e perda de massa muscular em diversas condições, como nas doenças reumatológicas pediátricas; Objetivo: O objetivo deste estudo foi avaliar a eficácia e a segurança da suplementação de creatina em pacientes com DM de início juvenil; Métodos: Trata-se de um estudo duplo-cego, crossover, balanceado e controlado por placebo. Todos os voluntários (n = 15) receberam dois tratamentos, a saber: creatina (0,1 g/kg/dia) ou dextrose (placebo - 0,1 g/kg/dia). Para cada tratamento, o período de suplementação foi de 12 semanas, interpassadas por um período de washout de oito semanas. A ordem dos tratamentos foi determinada de forma aleatória e contrabalanceada. Tanto nos períodos pré-suplementação, como nos períodos pós-suplementação foram avaliadas a força e função musculares (desfechos primários), além da composição corporal, densidade mineral óssea, marcadores bioquímicos do remodelamento ósseo, citocinas inflamatórias, aptidão aeróbia, qualidade de vida, parâmetros relacionados à atividade da doença, consumo alimentar e conteúdo intramuscular de fosforilcreatina. Nos mesmos períodos de tempo, a segurança da intervenção foi avaliada por parâmetros laboratoriais e por clearance de 51Cr-EDTA. Os eventos adversos foram registrados durante todo o estudo; Resultados: Não houve diferença significativa no conteúdo intramuscular de fosforilcreatina entre as condições, antes e após as intervenções (Creatina - Pré: 21,4 ± 5,3/Pós: 20,6 ± 2,7, delta escore = -0,3 ± 2,5 mmol/kg peso úmido; Placebo - Pré: 20,4 ± 3,7/Pós: 20,7 ± 3,6, delta escore = -0,1 ± 4,2 mmol/kg peso úmido, p = 0,45...

Introduction: Juvenile dermatomyositis (JDM) is an autoimmune idiopathic disease characterized by skin rashes, insidious loss of muscle mass, symmetrical proximal muscle weakness, decreased physical capacity, and fatigue. In this context, creatine supplementation has emerged as a promising non-pharmacological therapeutic strategy to counteract muscle dysfunction and low lean mass in a variety of conditions, including in pediatric and rheumatic diseases. Objective: To examine the safety and efficacy of creatine supplementation in Juvenile Dermatomyositis (JDM) patients; Methods: JDM patients (n = 15) received placebo or creatine supplementation (0.1 g/kg/d) in a randomized, crossover, double-blind design. Subjects were assessed at baseline and after 12 weeks, with an 8-week washout period. Primary outcome was muscle function. Secondary outcomes included body composition, bone mineral density, biochemical markers of bone remodeling, inflammatory cytokines, aerobic conditioning, health-related quality of life, disease-related parameters, dietary intake and muscle phosphorylcreatine (PCR) content. Safety was assessed by laboratory parameters and kidney function measurements such as 51Cr-EDTA clearance; Results: Intramuscular PCR content was not significantly different between creatine and placebo before or after the intervention (Creatine - Pre: 21.4 ± 5.3, Post: 20.6 ± 2.7, delta score = -0.3 ± 2.5 mmol/kg wet muscle, ES = -0.15; Placebo - Pre: 20.4 ± 3.7, Post: 20.7 ± 3.6, delta score = -0.1 ± 4.2 mmol/kg wet muscle, ES = -0.15; 95% CI for delta score = -2.8 ± 2.4, p = 0.45...

The ergogenic effect of beta-alanine combined with sodium bicarbonate on high-intensity swimming performance.

We investigated the effect of beta-alanine (BA) alone (study A) and in combination with sodium bicarbonate (SB) (study B) on 100- and 200-m swimming performance. In study A, 16 swimmers were assigned to receive either BA (3.2 g·day(-1) for 1 week and 6.4 g·day(-1) for 4 weeks) or placebo (PL; dextrose). At baseline and after 5 weeks of supplementation, 100- and 200-m races were completed. In study B, 14 were assigned to receive either BA (3.2 g·day(-1) for 1 week and 6.4 g·day(-1) for 3 weeks) or PL. Time trials were performed once before and twice after supplementation (with PL and SB), in a crossover fashion, providing 4 conditions: PL-PL, PL-SB, BA-PL, and BA-SB. In study A, BA supplementation improved 100- and 200-m time-trial performance by 2.1% (p = 0.029) and 2.0% (p = 0.0008), respectively. In study B, 200-m time-trial performance improved in all conditions, compared with presupplementation, except the PL-PL condition (PL-SB, +2.3%; BA-PL, +1.5%; BA-SB, +2.13% (p < 0.05)). BA-SB was not different from BA-PL (p = 0.21), but the probability of a positive effect was 78.5%. In the 100-m time-trial, only a within-group effect for SB was observed in the PL-SB (p = 0.022) and BA-SB (p = 0.051) conditions. However, 6 of 7 athletes swam faster after BA supplementation. The probability of BA having a positive effect was 65.2%; when SB was added to BA, the probability was 71.8%. BA and SB supplementation improved 100- and 200-m swimming performance. The coingestion of BA and SB induced a further nonsignificant improvement in performance.

Acute effects of isocaloric meals with different fiber and antioxidant contents on inflammatory markers in healthy individuals.

Chronic inflammation contributes to the pathophysiology of many chronic diseases. Dietary fibers and antioxidants may exert anti-inflammatory effects. The objective of this study was to determine whether meals with different fibers and antioxidants may elicit a different response in inflammatory markers in healthy volunteers. On 3 separate days, subjects (n = 8) consumed one of three isocaloric meals with different antioxidant (vitamin E, selenium and ß-carotene) and fiber content (high, intermediate and low) in a randomized crossover design. Blood samples were collected at different times: 0 min (before the meal), and 30 and 240 min after the meal. Plasma interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-α, glucose and insulin content were evaluated at each time point. There were no significant differences for any of the parameters at baseline. Furthermore, plasma levels of TNF-α, IL-6 and IL-10 were unchanged at the 30- and 240-min time points whatever meal consumed. Moreover, the cytokine responses to glucose and insulin intake were not significantly different between experimental conditions. In conclusion, isocaloric meals with different fiber, ß-carotene, vitamin E and selenium contents do not acutely affect inflammatory markers in healthy young males.

Nutritional status and food intake of patients with systemic psoriasis and psoriatic arthritis associated.

OBJECTIVE: To identify the nutritional status and food intake of individuals with systemic psoriasis and psoriatic arthritis associated. METHODS: This is an exploratory and cross-sectional study with 34 men aged between 19 and 60 years seen at a Psoriasis Center. Participants were divided into systemic psoriasis group and arthritic-systemic psoriasis associated group. For nutritional assessment we used anthropometry, bioelectrical impedance analysis and whole-body plethysmography. Clinical and nutritional information were assessed using the clinical and nutritional history-taking, and the 24-hour dietary recall. For statistics the general linear model test (p < 0.05) was used. RESULTS: According to the body mass index 29.4% patients (n = 10) were eutrophic, 41.2% (n = 14) overweight and 29% (n = 10) obese. Almost all individuals (60%; n = 21) had body fat percentage above normal levels (> 25%) and a high risk for metabolic complications according to the waist circumference and the obesity index, however, there were no statistically significant differences between groups. The mean food intake, total fat, calories and protein were above recommended levels, being 58.8% for lipids (319.17 +/- 241.02 mg of cholesterol and 17.42 +/- 11.4 g saturated fatty acids); 29.4% for calories and 67.6% for proteins. Thus, regardless of the psoriasis type, an excessive consumption of calories, lipids, fatty acids, cholesterol and a higher incidence of overweight were found. CONCLUSION: The sample showed an abnormal nutritional condition, an increased risk for chronic diseases related to obesity, worsening of the psoriatic lesions, and poor quality of life.

Nutritional status and food intake of patients with systemic psoriasis and psoriatic arthritis associated / Estado nutricional e consumo alimentar de pacientes com psoríase dos tipos sistêmica e artropática sistêmica associada

Objective: To identify the nutritional status and food intake of individuals with systemic psoriasis and psoriatic arthritis associated. Methods: This is an exploratory and cross-sectional study with 34 men aged between 19 and 60 years seen at a Psoriasis Center. Participants were divided into systemic psoriasis group and arthriticsystemic psoriasis associated group. For nutritional assessment we used anthropometry, bioelectrical impedance analysis and wholebody plethysmography. Clinical and nutritional information were assessed using the clinical and nutritional history-taking, and the 24-hour dietary recall. For statistics the general linear model test (p < 0.05) was used. Results: According to the body mass index 29.4% patients (n = 10) were eutrophic, 41.2% (n = 14) overweight and 29% (n = 10) obese. Almost all individuals (60%; n = 21) had body fat percentage above normal levels (> 25%) and a high risk for metabolic complications according to the waist circumference and the obesity index, however, there were no statistically significant differences between groups. The mean food intake, total fat, calories and protein were above recommended levels, being 58.8% for lipids (319.17 ± 241.02 mg of cholesterol and 17.42 ± 11.4 g saturated fatty acids); 29.4% for calories and 67.6% for proteins. Thus, regardless of the psoriasis type, an excessive consumption of calories, lipids, fatty acids, cholesterol and a higher incidence of overweight were found. Conclusion: The sample showed an abnormal nutritional condition, an increased risk for chronic diseases related to obesity, worsening of the psoriatic lesions, and poor quality of life.

Objetivo: Identificar o estado nutricional e o consumo alimentar de indivíduos com psoríase sistêmica e artropática associada. Métodos: Pesquisa exploratória e transversal, na qual avaliaram-se 34 homens, de 19 a 60 anos, atendidos em um Centro de Psoríase, separando-os em Grupo PS (com psoríase sistêmica) e Grupo PAS (com sistêmica mais artropática). A avaliação nutricional deu-se pelo emprego da antropometria; bioimpedância e plestimografia de corpo inteiro. Aspectos clínicos e nutricionais foram investigados pela anamnese clínica, nutricional e recordatório de 24 horas. Empregou-se o teste General Linear Model (p < 0,05) para avaliação estatística. Resultados: Segundo Índice de Massa Corporal, 29,4% (n = 10) apresentaram-se eutróficos; 41,2% (n = 14) com sobrepeso e 29% (n = 10) com obesidade. A maioria dos avaliados (60%; n = 21) apresentou valor da porcentagem de gordura (avaliada pela antropometria, bioimpedância e plestimografia de corpo inteiro) acima da normalidade (> 25%) e com risco alto para complicações metabólicas segundo CC e índice de obesidade, sem diferença estatística significativa entre os grupos. O consumo alimentar médio de lipídio, calorias e proteína apresentou-se acima do recomendado, sendo 58,8% para os lípides (319,17 ± 241,02 mg de colesterol e 17,42 ± 11,4 g de ácidos graxos saturados); 29,4% para as calorias e 67,6% para as proteínas. Assim, independentemente do tipo de psoríase, encontrou-se consumo excessivo de calorias, lípides, colesterol e ácidos graxos, além de maior ocorrência de excesso de peso. Conclusão: A amostra apresentou estado nutricional comprometido, aumento do risco para doenças crônicas relacionadas à obesidade, agravamento das lesões e má qualidade de vida.

Efeitos terapêuticos do treinamento físico em pacientes com doenças reumatológicas pediátricas / Therapeutic effects of exercise training in patients with pediatric rheumatic diseases

Ao longo das últimas décadas, o papel do exercício em doenças reumatológicas tem sido bastante explorado. Sabe-se, atualmente, que a prática de atividade física promove inúmeros benefícios ao paciente com osteoporose, osteoartrite, lúpus eritematoso sistêmico, esclerose sistêmica, miopatias idiopáticas inflamatórias, fibromialgia e artrite reumatoide. Dessa forma, o exercício físico tem sido considerado ferramenta valiosa no tratamento do paciente reumático. Os efeitos terapêuticos do treinamento físico em doenças reumatológicas pediátricas também têm sido alvos recentes de investigação. Em conjunto, os estudos têm revelado grande potencial terapêutico do exercício para pacientes com artrite idiopática juvenil, lúpus eritematoso sistêmico juvenil, dermatomiosite juvenil, fibromialgia juvenil e outras causas de dor crônica. Esta revisão narrativa tem como objetivos familiarizar o reumatologista pediátrico ao campo da ciência do exercício, discutir os potenciais benefícios do exercício físico na reumatologia pediátrica, com ênfase nas perspectivas desse promissor campo de atuação clínica e científica, e apresentar modelos práticos de exame de pré-participação e contraindicações ao exercício físico.

Over the past decades, the role of exercise training in rheumatic diseases has been largely explored. Currently, physical activity is well known to benefit patients with osteoporosis, osteoarthritis, systemic lupus erythematosus, systemic sclerosis, idiopathic inflammatory myopathy, fibromyalgia and rheumatoid arthritis. Therefore, exercise training has been considered a valuable tool for treating rheumatic patients. The therapeutic effects of exercise training have also been investigated in pediatric rheumatic diseases. Collectively, studies have revealed the therapeutic potential of exercise in juvenile idiopathic arthritis, juvenile systemic lupus erythematosus, juvenile dermatomyositis, juvenile fibromyalgia and other causes of chronic pain. The aim of this review is to familiarize the pediatric rheumatologist with the exercise science field; discuss the potential benefits of exercise training in pediatric rheumatic diseases, emphasize both research and clinical perspectives of this promising field; and propose practical models of pre-participation examinations and contraindications to exercise.

Therapeutic effects of exercise training in patients with pediatric rheumatic diseases.

Over the past decades, the role of exercise training in rheumatic diseases has been largely explored. Currently, physical activity is well known to benefit patients with osteoporosis, osteoarthritis, systemic lupus erythematosus, systemic sclerosis, idiopathic inflammatory myopathy, fibromyalgia and rheumatoid arthritis. Therefore, exercise training has been considered a valuable tool for treating rheumatic patients. The therapeutic effects of exercise training have also been investigated in pediatric rheumatic diseases. Collectively, studies have revealed the therapeutic potential of exercise in juvenile idiopathic arthritis, juvenile systemic lupus erythematosus, juvenile dermatomyositis, juvenile fibromyalgia and other causes of chronic pain. The aim of this review is to familiarize the pediatric rheumatologist with the exercise science field; discuss the potential benefits of exercise training in pediatric rheumatic diseases, emphasize both research and clinical perspectives of this promising field; and propose practical models of pre-participation examinations and contraindications to exercise.

Tempo de recuperação entre a pesagem e o início das lutas em competições de judô do Estado de São Paulo / Recovery time between weigh-in and first match in State level judo competitions

A perda rápida de peso é altamente prevalente entre atletas de luta. No judô, há um período entre a pesagem e o início da competição no qual atletas podem se recuperar da perda de peso. Apesar desse tempo ser determinante para o desempenho, nenhum estudo avaliou seu padrão de duração. Este estudo objetivou determinar o padrão de duração do tempo entre a pesagem e o início das lutas em competições oficiais de judô. Foram analisados 117 atletas do sexo masculino (classes juvenil, júnior e sênior) durante duas competições oficiais. Registraram-se o horário de término da pesagem e do início da primeira luta de cada atleta. O tempo médio de recuperação foi de aproximadamente quatro horas. A maior parte dos atletas teve aproximadamente 2,5 - 5 horas entre a pesagem e o início das lutas. O período para a classe sênior foi significantemente maior do que o das classes júnior e juvenil (p < 0,01) e o da classe júnior foi significantemente maior do que o da classe juvenil (p < 0,01). Conclui-se que os tempos de recuperação aqui registrados são provavelmente padrões para competições de mesmo porte e esquema organizacional, embora os tempos específicos para as classes etárias possam se modificar. O período que a maioria dos atletas teve para recuperar-se é suficiente para adequada ingestão de alimentos e líquidos, o que minimiza o impacto da perda de peso sobre o desempenho e estimula a pratica de métodos agressivos de perda rápida de peso.

Rapid weight loss is highly prevalent among combat sport athletes. After the weigh-in, there is a period in which athletes can refeed and rehydrate before the combats. The length of this recovery period is determinant for performance in the subsequent combats. No study, however, has determined the time patterns of such period. The purpose of this study was to determine the patterns of recovery time between the weigh-in and the first combats during judo competitions. One hundred and seventeen juvenile, junior and senior male athletes were analyzed during two São Paulo state competitions. The time at which each athlete has finished the weight-in and the time at which they have started the first combat were recorded and then the recovery period between weigh-in and combats was calculated. Average recovery time was approximately four hours. Most athletes had a 2.5 to 5-hour recovery time between the weigh-in and the first combat. Senior athletes had a significant longer recovery time compared to junior and juvenile (p < 0.001). Junior athletes also had a significant longer recovery time in comparison to juvenile athletes (p < 0.001). In conclusion, the patterns for recovery time presented in this study are likely to be a standard if competitions of similar size and organization are considered. Recovery period for the majority of athletes is enough to allow them to refeed and rehydrate, so the impact of weight loss on performance would be minimal. This can stimulate athletes to engage in potentially harmful rapid weight loss procedures.

Avaliação qualitativa e quantitativa do consumo alimentar de mulheres fisicamente ativas / Qualitative and quantitative evaluation of nourishing consumption of physically active women / Evaluación cualitativa y cuantitativa del consumo alimentario de mujeres físicamente activas

O presente estudo teve como objetivo avaliar quanti e qualitativamente o consumo alimentar de mulheres fisicamente ativas, com a finalidadede investigar o seu padrão alimentar e tecer recomendações de consumo alimentar com base na Pirâmide Alimentar Brasileira. Para tanto, foram selecionadas em 3 academias de médio e grande porte, 83 fichas de anamnese alimentar e registro de 24 horas, para a análise das variáveis antropométricas:peso, estatura, índice de massa corporal, além do gasto e do consumo energético total, assim como o consumo alimentar qualitativo em 8 diferentes grupos alimentares segundo a Pirâmide Alimentar Brasileira. Constatou-se baixo consumo energético total, frente ao gasto em atividades físicas diárias,acompanhado de baixíssima ingestão dos grupos dos pães e cereais, hortaliças, frutas e lácteos; e baixo consumo dos grupos das leguminosas e açúcares. Globalmente, nossos resultados apontaram uma alimentação abaixo das recomendações, nos âmbitos quanti e qualitativo dessas mulheres fisicamente ativas. Dessa forma, em futuros desdobramentos, um instrumento de obtenção mais fidedigno e representativo do consumo habitual deve ser empregado,para confirmar as hipóteses levantadas neste estudo exploratório. Como recomendação nutricional para esse grupo, seria desejável aumentar o consumo energético proveniente do grupo dos pães e cereais, leite e das FLV (frutas, legumes e verduras), cujo padrão é condizente, segundo diversas diretrizes nacionais e internacionais, com a adequação nutricional para a qualidade de vida e manutenção de um padrão de vida ativo fisicamente.

This study aimed to evaluate quantitatively and qualitatively the nourishing consumption of physically active women in order to investigatetheir nourishing style and to weave recommendations of nourishing consumption base on the Brazilian Nourishing Pyramid. For that, we selected, in 3 reputed fitness centers 83 cards of nourishing anamnesis and registry of 24 hours for analysis of the anthropometric variables: weight, height, index of corporal mass, besides the cost and total power consumption, as well as the qualitative nourishing consumption in 8 different nourishing groups according to the Brazilian Nourishing Pyramid. We observed total power consumption inferior to the cost in daily physical activities, accompanied by lowest ingestion by the groups of breads and milky cereals, vegetables, fruits and milk by products; and low consumption of the groups of leguminous and sugars. In globalterms, our results have indicated feeding underthe recommendations both in quantitative and qualitative terms of those physically active women; thus, in future deployments, a more reliable and representative instrumentfor habitual consumption must be used in order to confirm the assumptions formulated in this exploratory study. As nutritional recommendation for that group, it would be desirable to increase power coming from the consumption of thegroup of breads and cereals, milk, and FLV (fruits, leguminous and vegetables), whose register is agreed, according to diverse national and international directives, with nutritional adjustment for quality of life and maintenance of a physically active life style.

Este estudio ha tenido como objetivo evaluar cuanti y cualitativamente el consumo alimentario de mujeres físicamente activas con la finalidadde investigar su padrón alimentario y tejer recomendaciones de consumo alimentario con base en la Pirámide Alimentaria Brasileña. Para eso, han sido seleccionadas, en 3 academias de medio y grande porte, 83 fichas de anamnesis alimentaria y registro de 24 horas para análisis de las variables antropométricas: peso, talla, índice de masa corporal, además del gasto y del consumo energético total, así como el consumo alimentario cualitativo en 8 diferentes grupos alimentarios según la Pirámide Alimentaria Brasileña. Constatóse bajo consumo energético total delante del gasto en actividades físicas diarias, acompañado de bajísima ingestión de los grupos de los panes y cereales, hortalizas, frutas y lácteos; y bajo consumo de los grupos de las leguminosas y azúcares. En términos globales, nuestros resultados han indicado alimentación debajo de las recomendaciones en los ámbitos cuanti y cualitativo de esas mujeres físicamente activas; de esa manera, en futuros desdoblamientos, debe ser empleado un instrumento de obtención más confiable y representativadel consumo habitual a fin de confirmar los supuestos formulados en este estudio exploratorio. Como recomendación nutricional para ese grupo, sería deseable aumentar el consumo energético proveniente del grupo de los panes y cereales, leche, y de las FLV (frutas, legumbres y verduras), cuyo padrón es acorde, según diversas directrices nacionales e internacionales, con adecuación nutricional para calidad de vida y mantenimiento de un padrón de vidafísicamente activo.

An overview of the therapeutic effects of leucine supplementation on skeletal muscle under atrophic conditions.

The characterization of the mechanisms underlying skeletal muscle atrophy under different conditions has been a constant focus of research. Among anti-atrophic therapies, amino acid supplementation, particularly with leucine, has received a lot of attention. Supplementation has been shown to have remarkable effects on muscle remodeling through protein turnover modulation. This may then impact physiological parameters related to muscle function, and even quality of life. In light of this, leucine supplementation could be a useful therapy for mitigating the atrophic effects of catabolic conditions. The purpose of this review is to present the major results of human studies evaluating the effects of leucine supplementation on structure and function of skeletal muscle in atrophic conditions such as muscle disuse, sarcopenia, and cancer.